World Stroke Organization 
Description: Join us for a comprehensive webinar exploring the intricate relationship between stroke and gender, with a focus on cis and trans women. Delving into current clinical trials, hormonal therapies, and stroke prevention strategies, this session will shed light on critical issues often overlooked. We will navigate these critical issues at the intersection of gender, stroke, and healthcare, striving for greater understanding, inclusivity, and effective prevention strategies. This webinar is part of our #WomenInStroke project.
Chair: Dr. Theodoros Karapanayotides (Greece)
Scientific Program:
- Are females underrepresented in clinical trials? – Dr. Zuzana Gdovinova (Slovakia)
- Consequences of limited data on prevention & treatment
- Importance of diverse study populations
- Hormonal replacement therapy and stroke risk – Dr. Xabier Urra (Spain)
- Benefits & risks, controversies & recent research findings
- Alternative approaches to manage postmenopausal symptoms
- Stroke risk and stroke prevention in transgender individuals – Dr. Susanna (Yvonne) Zuurbier (Belgium)
- Risk factors
- Healthcare disparities, inclusive environment
Date and Time: 26th of March 2024, 3pm (CET)
Webinar Details
Speakers:
- Dr. Zuzana Gdovinova, Professor of Neurology from Charles University in Prague and Head of the Department of Neurology at the Faculty of Medicine, P.J. Šafárik University and University Hospital L. Pasteur in Košice, Slovakia
- Dr. Xabier Urra, Vascular Neurologist, Head of Neurology at Hospital Clínic Barcelona, Spain
- Dr. Susanna (Yvonne) Zuurbier, Neurologist, Neurovascular Consultant, University Hospital Antwerp, Belgium
Moderator:
- Dr. Theodoros Karapanayotides, Associate Professor of Neurology at the Aristotle University of Thessaloniki, Greece
;
Dianne Daley
A as employee over 50 yrs old I can appreciate this sort of information and as well learned who menopause can affect High Blood Pressure and Stroke in women. This food for digesting and help me better catering to patient care.